First nasal spray Ebola vaccine found to ‘offer long-term protection against deadly virus’
Scientists at the University of Texas are developing the breathable vaccine
It has been shown to protect monkeys against the deadly virus
Next step is to test vaccine on humans in phase one clinical trials
Researchers said respiratory vaccine could overcome logistical problems of storing, transporting and administering injectable vaccines
By Lizzie Parry
DailyMailUK
4 November 2014
A nasal spray, being developed as a potential vaccine for the deadly Ebola virus, has been found to protect monkeys in pre-clinical trials.
Scientists at the University of Texas discovered the breathable vaccine offers long-term protection against the virus.
Since the current outbreak erupted in West Africa earlier this year, almost 5,000 people have lost their lives – the majority in Sierra Leone, Liberia and Guinea.
A number of injectable experimental vaccines are being trialled in the US, UK and Mali, with plans to extend human trials into other parts of Europe, Gabon and Kenya.
The Rest…HERE
